FUE Hair Transplant in Ukraine

FUE stands for follicular unit extraction: the surgeon removes individual follicular units, natural groups of one to four hairs, from the donor area with a cylindrical punch 0.8–1.0 mm in diameter. Each graft is removed individually, with no linear incision or stitches, and the harvesting sites are left with pinpoint wounds that heal within a few days.

The back of the head and the temples serve as the donor area for a reason. Follicles in this area are genetically insensitive to dihydrotestosterone, the hormone that, in hereditary alopecia, gradually thins the hair on the crown and at the front of the head. Transplanted to a new site, they usually keep this property and grow where your own hair has already fallen out.

The older FUT method works differently: a strip of skin is cut from the back of the head, the edges are sutured, and the follicular units are dissected from it under a microscope. The strip yields more grafts in a single session and costs less, but it leaves a linear scar along the back of the head that is visible with a short haircut. That is why FUE has displaced it in private practice.

The key point to understand before surgery: the donor supply is limited and does not regenerate. Over a lifetime roughly 4,000–8,000 grafts can be safely taken from it, and every graft removed is gone for good. The first operation is therefore not a "trial run": it draws on a reserve that has to last for decades.

MediUkraine is a service that finds and coordinates treatment; it is not a clinic. We select a medical centre and a surgeon with the relevant expertise, agree the date of the operation and support patients, including those travelling from abroad. Decisions on indications, the scope of the procedure and the technique are made by the doctor after an in-person examination.

FUE (follicular unit extraction) is the basic technique of modern hair transplantation. The surgeon marks the donor area at the back of the head and the temples, anaesthetises it, and then uses a cylindrical 0.8–1.0 mm punch to separate the follicular units from the surrounding tissue one at a time and remove them with forceps. A single session yields anywhere from a few hundred to three or four thousand grafts, with no linear incision or stitches.

The punch can be manual or motorised. Manual harvesting is slower and causes less mechanical trauma; a micromotor works faster and passes through dense fibrous skin more reliably. The key indicator here is not the name of the instrument but the transection rate, the percentage of grafts damaged during harvesting. In experienced hands it stays below 5%, and it is this rate that determines how much hair eventually grows.

The second stage is creating the recipient sites in the transplant area. The surgeon makes micro-incisions at the same angle and in the same direction in which your own hair grew: it is the angle, not the number of grafts, that makes the result undetectable. Density is set at this point too, usually 30–45 grafts per square centimetre. Trying to "pack in" more does not add hair; it impairs the blood supply to the area.

DHI differs from FUE only in the implantation stage: the doctor loads the follicular unit into a Choi implanter, a hollow needle with a plunger, and in one movement creates the channel and places the graft, without creating the sites in advance. This shortens the time the graft spends outside the body and makes it possible to avoid shaving the whole area, but it costs more. Harvesting is the same, so DHI is not an alternative to FUE but a variant of it; it is covered on a separate page.

Planning the hairline is the most important part of the conversation with the surgeon. The line is placed not where it was at twenty, but where it will look natural at forty and at sixty: a hairline set too low in a young patient turns over the years into a strip of hair above the forehead with a bald patch showing through behind it. The doctor takes into account age, family history and the forecast of further thinning. A surgeon who lowers the line as far as the patient asks is a warning sign.

Volume is calculated for the specific area. The front hairline with the temple corners takes 1,500–2,500 grafts, the frontal area with the transition zone 2,500–3,500 and the crown from 1,500 to 2,500, and the supply is often not enough to cover both the crown and the frontal area in one session. The crown is also geometrically difficult: hair there grows in a whorl, and that pattern is harder to reproduce. When the supply is limited, the frontal area is covered first, because it frames the face.

The donor area is assessed before surgery: the density per square centimetre, the thickness of the hair shafts and the size of the area insensitive to androgens are measured. No more than 20–25% of the follicular units from a given area are taken in one session; exceeding that leaves a thinned-out back of the head that nothing can fix.

Graft survival in properly performed series is 85–95% at twelve months: it is affected by the time the graft spends outside the body, the temperature of the solution, the blood supply to the area and whether the patient smokes. A promise of "98% guaranteed" is marketing: some grafts always die.

The most important thing advertised packages leave out: a transplant does not stop androgenetic alopecia. The transplanted follicles stay in place, but your own hair around them keeps thinning. Without treatment, two or three years later the patient is left with a dense transplanted strip with an empty area around it and needs another operation, drawing on the non-renewable supply a second time. That is why evidence-based medication is prescribed before the procedure and continued long term afterwards.

Transplants are not performed during active alopecia areata: the immune attack will destroy the transplanted follicles just as it does your own. Unstable scarring alopecias are not operated on either (lichen planopilaris, frontal fibrosing alopecia and folliculitis decalvans): in these cases a transplant is considered only after at least a year of inactive disease. Uncontrolled diabetes, clotting disorders and a tendency to keloids call for caution.

The overall complication rate of FUE in large series is roughly 1–5%; most often it is superficial folliculitis in the transplant area, which clears within a few days with topical treatment. Skin necrosis is rare, occurring in roughly 0.1% of cases, and is almost always linked to an excessive density of recipient sites. Temporary loss of sensation in the donor area is common and passes within a few months; persistent loss is rare. Pinpoint white scars at the harvesting sites always remain: they cannot be seen under a hairstyle, but they are noticeable with a clipper cut at grade one or two.

Expect swelling for the first two or three days. It appears on the second day, often moves down onto the forehead and eyelids, sometimes looks dramatic, and goes away on its own by the end of the first week. Sleep with the head of the bed raised, and do not touch the transplant area.

Small scabs form at the recipient sites. Do not pick them: gentle washing starts on days five to seven, following the clinic's routine, and by day 10–14 the scabs come away on their own. By then most patients are back to their usual activities, apart from sport, saunas, swimming pools and direct sun, which are put off for about a month.

After 2–4 weeks the transplanted hair falls out, and this is what frightens people most. In fact it is an expected phase: the shaft drops away, while the follicle under the skin stays alive and enters a resting phase. The phenomenon is called shock loss; it also affects some of your own hair around the transplant area, and that hair usually grows back too.

Growth usually begins from month 3–4. At first fine, colourless hair appears, which gradually coarsens and gains pigment. By the sixth month roughly half of the result is visible, and the final result is assessed at 12–18 months: the crown matures noticeably more slowly than the frontal area.

Graft survival in properly performed series is 85–95%, but only a doctor can forecast the result for a particular patient, after an in-person examination. If after a year the density turns out lower than expected or the alopecia has progressed further, a second session is planned, smaller in volume and drawing on the supply that was deliberately held back.

Follow-up check-ups are usually scheduled for day 10–14 and then at three, six and twelve months. Patients from abroad can complete these remotely using standardised photos; if needed, MediUkraine arranges a video call with the same surgeon.